Three-Pronged attack on advanced lung cancer shows promise
NCT ID NCT05299125
Summary
This study is testing a combination of three drugs (amivantamab, lazertinib, and pemetrexed) as the first treatment for people with advanced non-small cell lung cancer that has spread and has specific genetic changes (EGFR mutations). The goal is to see if this powerful combination can safely keep the cancer from growing for a longer time compared to older treatments. About 54 adults who haven't had treatment for their advanced cancer will receive the drugs until the cancer worsens or side effects become too severe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NON-SMALL CELL LUNG CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BP - A Beneficência Portuguesa de São Paulo
São Paulo, 01323-030, Brazil
-
Centro de Pesquisa em Oncologia do Hospital São Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, 91751-443, Brazil
-
Centro de Tratamento de Tumores Botafogo (Oncoclínicas)
Rio de Janeiro, 22250-905, Brazil
-
Hospital Erasto Gaertner
Curitiba, Paraná, 81520-060, Brazil
-
Hospital Evangélico de Cachoeiro de Itapemirim
Cachoeiro de Itapemirim, Espírito Santo, 29308-065, Brazil
-
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP
Ribeirão Preto, São Paulo, 14015-010, Brazil
-
Hospital de Amor de Barretos
Barretos, São Paulo, 14784400, Brazil
-
Hospital de Base de São José do Rio Preto
São José do Rio Preto, São Paulo, 15090-000, Brazil
-
ICESP - Instituto do Câncer do Estado de São Paulo
São Paulo, 01246-000, Brazil
-
INCA - Instituto Nacional de Câncer
Rio de Janeiro, 20230-130, Brazil
-
Irmandade da Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90050-170, Brazil
-
Liga Norte Riograndense Contra o Câncer
Natal, Rio Grande do Norte, 59062-000, Brazil
-
Pronutrir - Oncologia e Nutrição
Fortaleza, Ceará, 60810-180, Brazil
-
São Camilo Oncologia
São Paulo, 04014-002, Brazil
Conditions
Explore the condition pages connected to this study.